Skip to main content

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now

Asfotase alfa Biosimilar – Anti-TNSALP fusion protein – Research Grade

Reference:
Size

100ug, 1MG

Brand

ProteoGenix

Product type

Recombinant Proteins

Expression system

XtenCHO

Applications

Elisa, WB

Product nameAsfotase alfa Biosimilar - Anti-TNSALP fusion protein - Research Grade
SpeciesHomo sapiens
Expression systemEukaryotic expression
Purity>90% by SDS-PAGE.
Buffer0.01M PBS, pH 7.4.
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /Synonymsanti-TNSALP, Alkaline phosphatase liver/bone/kidney isozyme, AP-TNAP, Alkaline phosphatase, tissue-nonspecific isozyme, ALPL
ReferencePX-TA2032
NoteFor research use only.
IsotypeFusion - [ALPL (alkaline phosphatase, TNSALP, tissue non-specific alkaline phosphatase) 18-502]2 - IGHG1 Fc (Fragment constant) - Asp-Ile-deca-aspartate

Description of Asfotase alfa Biosimilar - Anti-TNSALP fusion protein - Research Grade

Asfotase Alfa Biosimilar – Anti-TNSALP Fusion Protein

Asfotase alfa is a recombinant fusion protein designed to mimic the activity of tissue-nonspecific alkaline phosphatase (TNSALP), an enzyme involved in bone mineralization and phosphate metabolism. Reduced activity of TNSALP leads to accumulation of substrates such as inorganic pyrophosphate, which interferes with normal skeletal development.

This Asfotase alfa biosimilar is produced as a research-grade recombinant protein to support studies investigating alkaline phosphatase activity, metabolic bone disorders, and enzyme replacement strategies.

Biological Background

Tissue-nonspecific alkaline phosphatase plays a key role in regulating phosphate metabolism and mineral deposition in bone tissue. Deficiency of this enzyme is associated with hypophosphatasia, a rare metabolic disease characterized by impaired bone mineralization.

Because of its central role in phosphate metabolism, asfotase alfa has become an important research tool for scientists studying:

  • hypophosphatasia mechanisms
  • alkaline phosphatase enzyme activity
  • bone mineralization pathways
  • metabolic bone disorders

Relation to Strensiq®

The therapeutic protein Strensiq® (asfotase alfa) is an enzyme replacement therapy used clinically for hypophosphatasia. Research-grade asfotase alfa biosimilars allow laboratories to investigate the biological activity of this enzyme and to explore the molecular pathways involved in TNSALP deficiency.

Studying Strensiq asfotase alfa analogs helps researchers understand enzyme replacement approaches and the biochemical mechanisms regulating mineralization.

Research Applications

This Asfotase alfa fusion protein can support multiple experimental approaches including:

  • enzyme activity assays
  • hypophosphatasia pathway studies
  • alkaline phosphatase functional analysis
  • metabolic bone disease research

Asfotase Alfa Price and Cost

ProteoGenix offers some of the most competitive Asfotase alfa prices on the market for research-grade proteins. Our Asfotase alfa biosimilar is produced under controlled conditions to ensure high quality, consistency, and reliable performance in experimental applications.

For detailed information regarding Asfotase alfa price or cost, researchers and laboratories can request a quotation from our scientific team.

Related Services

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Asfotase alfa Biosimilar – Anti-TNSALP fusion protein – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below

    Cart (0 Items)

    Your cart is currently empty.

    View Products